According to Arena Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is $0.37 M. In 2019 the company made a revenue of $0.80 B an increase over the years 2018 revenue that were of $17.97 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2021 (TTM) | $0.37 M | |
2019 | $0.80 B | 4387.65% |
2018 | $17.97 M | -15.78% |
2017 | $21.33 M | -82.79% |
2016 | $0.12 B | 223.47% |
2015 | $38.32 M | 3.67% |
2014 | $36.97 M | -54.58% |
2013 | $81.39 M | 195.04% |
2012 | $27.58 M | 116.9% |
2011 | $12.71 M | -23.44% |
2010 | $16.61 M | 59.94% |
2009 | $10.38 M | 5.89% |
2008 | $9.8 M | -49.26% |
2007 | $19.33 M | -36.76% |
2006 | $30.56 M | 31.57% |
2005 | $23.23 M | 69.76% |
2004 | $13.68 M | 6.63% |
2003 | $12.83 M | -33.92% |
2002 | $19.42 M | 7.54% |
2001 | $18.05 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
GlaxoSmithKline GSK | $37.84 B | 10,147,097.33% | ๐ฌ๐ง UK |
Athersys ATHX | $0.08 M | -78.55% | ๐บ๐ธ USA |
Array Technologies ARRY | $1.57 B | 422,567.83% | ๐บ๐ธ USA |